Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients

Phase 2/3 Recruiting 70 enrolled Birch BioMed Inc Nutrasource Pharmaceutical and Nutraceutical Services, Inc. · collab

RandomizedParallel-groupTriple-blindBasic science

Summary

The goal of this study is to see how an ingredient called kynurenic acid (which we named "FS2") affects scar formation in people with burn injuries that need skin graft surgery. A cream with FS2 will be used on both the area where the skin graft was placed and the area where the skin was taken (donor site). The cream will be applied after the skin has healed. This study will help us understand if FS2 is safe and effective for mitigating skin scar formation in burn patients.

Timeline

Start: 2026-05-15
Primary completion: 2026-10-15
Completion: 2026-11-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	FS2	Unknown	0.5 %	Topical

Indications

No indication recorded.